Key facts
- This page summarizes Jack Bendheim's Form 4 filing for PHIBRO ANIMAL HEALTH CORP (PAHC).
- 9 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 16 Apr 2026, 20:25.
Jack Bendheim - 14 Apr 2026 Form 4 Insider Report for PHIBRO ANIMAL HEALTH CORP (PAHC)
- Reporting relationship
- President and CEO, Director, 10%+ Owner
- Issuer ticker
- PAHC
- Reported as of
- 14 Apr 2026
- Net transaction value
- -$1,201,595
- SEC form
- 4
- Accepted by SEC
- 16 Apr 2026, 20:25:42 UTC
- Prior SEC filing
- 31 Mar 2026
- Next SEC filing
- 23 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Judith Weinstein, as Attorney-in-Fact for Jack Bendheim
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jack Bendheim filed Form 4 for PHIBRO ANIMAL HEALTH CORP (PAHC) on 16 Apr 2026.
Change
- Previous filing in this sequence was filed on 31 Mar 2026.
- Current net transaction value: -$1,201,595.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (2)
CIK 0001241560
Primary reporting owner
BENDHEIM JACK
- Relationship
- President and CEO, Director, 10%+ Owner
- Address
- 300 FRANK W. BURR BLVD., STE 21, TEANECK
- Signature
- /s/ Judith Weinstein, as Attorney-in-Fact for Jack Bendheim
- Signature date
- 16 Apr 2026
CIK 0001601607
BFI Co., LLC
- Relationship
- 10%+ Owner
- Address
- 300 FRANK W. BURR BLVD., STE 21, TEANECK
- Signature
- /s/ Judith Weinstein, as Attorney-in-Fact for BFI Co., LLC
- Signature date
- 16 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PAHC
transaction
Class A Common Stock
Sale
- Transaction value
- $386,553
- Shares
- -6,548
- Change %
- -17%
- Price
- $59.03
- Shares after
- 31,572
- Date
- 14 Apr 2026
- Ownership
- See
- Footnotes
- F1, F2, F3
PAHC
transaction
Class A Common Stock
Sale
- Transaction value
- $386,553
- Shares
- -6,548
- Change %
- -17%
- Price
- $59.03
- Shares after
- 31,572
- Date
- 14 Apr 2026
- Ownership
- See
- Footnotes
- F1, F2, F3
PAHC
transaction
Class A Common Stock
Sale
- Transaction value
- $29,369
- Shares
- -492
- Change %
- -1.6%
- Price
- $59.69
- Shares after
- 31,080
- Date
- 14 Apr 2026
- Ownership
- See
- Footnotes
- F1, F3, F4
PAHC
transaction
Class A Common Stock
Sale
- Transaction value
- $29,369
- Shares
- -492
- Change %
- -1.6%
- Price
- $59.69
- Shares after
- 31,080
- Date
- 14 Apr 2026
- Ownership
- See
- Footnotes
- F1, F3, F4
PAHC
transaction
Class A Common Stock
Sale
- Transaction value
- $147,594
- Shares
- -2,623
- Change %
- -8.4%
- Price
- $56.27
- Shares after
- 28,457
- Date
- 15 Apr 2026
- Ownership
- See
- Footnotes
- F1, F3, F5
PAHC
transaction
Class A Common Stock
Sale
- Transaction value
- $147,594
- Shares
- -2,623
- Change %
- -8.4%
- Price
- $56.27
- Shares after
- 28,457
- Date
- 15 Apr 2026
- Ownership
- See
- Footnotes
- F1, F3, F5
PAHC
transaction
Class A Common Stock
Sale
- Transaction value
- $206,985
- Shares
- -3,618
- Change %
- -13%
- Price
- $57.21
- Shares after
- 24,839
- Date
- 15 Apr 2026
- Ownership
- See
- Footnotes
- F1, F3, F6
PAHC
transaction
Class A Common Stock
Sale
- Transaction value
- $206,985
- Shares
- -3,618
- Change %
- -13%
- Price
- $57.21
- Shares after
- 24,839
- Date
- 15 Apr 2026
- Ownership
- See
- Footnotes
- F1, F3, F6
PAHC
transaction
Class A Common Stock
Sale
- Transaction value
- $46,432
- Shares
- -799
- Change %
- -3.2%
- Price
- $58.11
- Shares after
- 24,040
- Date
- 15 Apr 2026
- Ownership
- See
- Footnotes
- F1, F3, F7
PAHC
transaction
Class A Common Stock
Sale
- Transaction value
- $46,432
- Shares
- -799
- Change %
- -3.2%
- Price
- $58.11
- Shares after
- 24,040
- Date
- 15 Apr 2026
- Ownership
- See
- Footnotes
- F1, F3, F7
PAHC
transaction
Class A Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +100,000
- Change %
- +416%
- Price
- $0.000000*
- Shares after
- 124,040
- Date
- 16 Apr 2026
- Ownership
- See
- Footnotes
- F3, F8
PAHC
transaction
Class A Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +100,000
- Change %
- +416%
- Price
- $0.000000*
- Shares after
- 124,040
- Date
- 16 Apr 2026
- Ownership
- See
- Footnotes
- F3, F8
PAHC
transaction
Class A Common Stock
Sale
- Transaction value
- $283,141
- Shares
- -5,190
- Change %
- -4.2%
- Price
- $54.56
- Shares after
- 118,850
- Date
- 16 Apr 2026
- Ownership
- See
- Footnotes
- F1, F3, F9
PAHC
transaction
Class A Common Stock
Sale
- Transaction value
- $283,141
- Shares
- -5,190
- Change %
- -4.2%
- Price
- $54.56
- Shares after
- 118,850
- Date
- 16 Apr 2026
- Ownership
- See
- Footnotes
- F1, F3, F9
PAHC
transaction
Class A Common Stock
Sale
- Transaction value
- $101,520
- Shares
- -1,850
- Change %
- -1.6%
- Price
- $54.88
- Shares after
- 117,000
- Date
- 16 Apr 2026
- Ownership
- See
- Footnotes
- F1, F3, F10
PAHC
transaction
Class A Common Stock
Sale
- Transaction value
- $101,520
- Shares
- -1,850
- Change %
- -1.6%
- Price
- $54.88
- Shares after
- 117,000
- Date
- 16 Apr 2026
- Ownership
- See
- Footnotes
- F1, F3, F10
PAHC
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 16,840
- Date
- 14 Apr 2026
- Ownership
- Direct
- Footnotes
- F11
PAHC
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 16,840
- Date
- 14 Apr 2026
- Ownership
- Direct
- Footnotes
- F11
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PAHC
transaction
Derivative
Class B Common Stock
Conversion of derivative security
- Transaction value
- Shares
- -100,000
- Change %
- -0.51%
- Price
- $0.000000*
- Shares after
- 19,496,034
- Date
- 16 Apr 2026
- Ownership
- See
- Underlying class
- Class A Common Stock
- Underlying amount
- 100,000
- Exercise price
- $0.000000
- Footnotes
- F3, F8
PAHC
transaction
Derivative
Class B Common Stock
Conversion of derivative security
- Transaction value
- Shares
- -100,000
- Change %
- -0.51%
- Price
- $0.000000*
- Shares after
- 19,496,034
- Date
- 16 Apr 2026
- Ownership
- See
- Underlying class
- Class A Common Stock
- Underlying amount
- 100,000
- Exercise price
- $0.000000
- Footnotes
- F3, F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 11 footnotes
Footnote F1
The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC ("BFI") on December 11, 2025.
Footnote F2
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.63 to $59.61. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4, 5, 6, 7, 9 and 10.
Footnote F3
The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Footnote F4
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.63 to $59.83.
Footnote F5
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.87 to $56.73.
Footnote F6
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.90 to $57.88.
Footnote F7
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.92 to $58.22.
Footnote F8
Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date.
Footnote F9
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.80 to $54.79.
Footnote F10
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.80 to $54.985.
Footnote F11
The reported securities are directly held by Jack Bendheim.